Reimagining the diagnosis of obstructive sleep apnea beyond the apnea-hypopnea index
Reimagining the diagnosis of obstructive sleep apnea beyond the apnea-hypopnea index
批准号:
10915769
负责人:
Ankit Ashok Parekh
金额:
$12.68万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-08-15 至 2024-07-31
关键词:
AffectAgeApneaAreaArousalBig DataBreathingCardiac healthCardiovascular DiseasesCardiovascular systemCerebrovascular DisordersChronicClassificationCohort StudiesCongestive Heart FailureDataData SetDevelopmentDiagnosisDiscriminationDiseaseDrowsinessElectroencephalographyEpidemiologyEquationEthnic OriginEventExcessive Daytime SleepinessFemaleFrequenciesFunctional disorderFundingFunding OpportunitiesFutureGenderHeart RateHomeHourHypertensionHypoxemiaHypoxiaMachine LearningManualsMeasuresMedicineMethodologyMorbidity - disease rateMulti-Ethnic Study of AtherosclerosisMyocardial InfarctionNational Heart, Lung, and Blood InstituteNatureNeurocognitiveNeurocognitive DeficitObstructionObstructive Sleep ApneaOutcomeOxygenOxyhemoglobinPatientsPersonsPhenotypePhysiologicalPhysiologyPolysomnographyPrediction of Response to TherapyProbabilityPrognosisReproducibilityRiskRisk AssessmentSeveritiesSeverity of illnessSleepSleep FragmentationsStrokeTestingThinkingUnited States National Institutes of HealthWeightWisconsinWithdrawalWorkadverse outcomeairway obstructioncardiometabolismcerebrovasculardisease diagnosisepidemiology studyhigh rewardhigh riskimprovedindexinginter-individual variationmalemortalitynovelrandomized, clinical trialsrate of changerespiratoryrisk predictionrisk stratificationtooltrait
中文摘要
项目摘要/摘要
阻塞性睡眠呼吸暂停(OSA)是一种与神经认知相关的常见慢性疾病
损伤、高血压以及突发的脑血管和心血管疾病。OSA当前已定义
通过测量阻塞性事件的频率(呼吸暂停低通气指数[AHI]),定义为
持续至少10秒的呼吸障碍,并与皮质觉醒和/或氧气有关
睡眠时的去饱和度。AHI仅对疾病严重程度的诊断和
在大型流行病学研究中预测短期和长期后果和越来越多的AHI证据
生理学和方法论上的限制导致了对重新思考方式的强烈抗议
我们目前诊断为阻塞性睡眠呼吸暂停综合征。该项目建议从标准的睡眠研究中提取指标来表征
阻塞性睡眠呼吸暂停综合征在三个不同领域的负担:呼吸、缺氧和觉醒。通风负担将是
根据整夜呼吸大小的分布自动量化,并结合
每一次呼吸都是阻碍。低氧负荷以自动方式从过夜氧气定量
减饱和度(基线饱和度和减饱和度事件之间的面积)。唤醒负荷的量化使用
与夜间睡眠深度和/或唤醒能力间接相关的脑电指标。这样做的两个首要目标是
项目是:1)使用呼吸负荷比AHI更好地识别OSA的存在,以及2)结合使用
呼吸性/缺氧性/觉醒负荷,其中组合的方程是机器学习的,以预测
短期(日间嗜睡)和长期(心血管死亡率、中风和充血性心脏事件
衰竭/心肌梗死)OSA的后果。通过使用现有数据(实验室内和家中
多导睡眠图),拟议的项目将利用大数据的力量来提炼和
改进我们诊断阻塞性睡眠呼吸暂停和评估不良后果风险的方法。
英文摘要
PROJECT SUMMARY/ABSTRACT
Obstructive sleep apnea (OSA) is a common chronic condition variably associated with neurocognitive
impairment, hypertension, and incident cerebrovascular and cardiovascular disease. OSA is currently defined
by measuring the frequency of obstructive events (apnea-hypopnea index [AHI]) defined by the number/hour of
obstructions to breathing lasting at least 10 seconds and associated with cortical arousals and/or oxygen
desaturation during sleep. The AHI has been only modestly useful for diagnosis of disease severity and for
predicting short- and long-term consequences in large epidemiologic studies and mounting evidence of AHI's
limitations on both physiological as well as methodological grounds has led to an outcry for rethinking the way
we currently diagnose OSA. This project proposes to extract, from standard sleep studies, metrics to characterize
the burden of OSA in three distinct domains: ventilatory, hypoxic and arousal. The ventilatory burden will be
quantitated automatically from the distribution of breath sizes in a whole night combined with the probability that
each breath is obstructive. Hypoxic burden is quantitated in an automated fashion from overnight oxygen
desaturation (area between baseline saturation and desaturation events). Arousal burden is quantitated using
EEG metrics that indirectly relate to sleep depth and/or arousability overnight. The two overarching aims of this
project are: 1) use ventilatory burden to identify presence of OSA better than AHI, and 2) use combination of
ventilatory/hypoxic/arousal burdens, where the equation for combination is machine-learned, to predict risk of
short- (daytime sleepiness) and long-term (cardiovascular mortality, stroke, and incident congestive heart
failure/myocardial infarction) consequences of OSA. By using existing data (in-lab and at-home
polysomnography) from >9000 subjects, the proposed project will harness the power of big data to refine and
improve the way we diagnose OSA and assess risk of adverse outcomes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Reimagining the diagnosis of obstructive sleep apnea beyond the apnea-hypopnea index
-
批准号:10515525
-
项目类别:
-
资助金额:$12.68万
-
财政年份:2022
-
负责人:Ankit Ashok Parekh
-
依托单位:
Reimagining the diagnosis of obstructive sleep apnea beyond the apnea-hypopnea index
-
批准号:10684100
-
项目类别:
-
资助金额:$12.68万
-
财政年份:2022
-
负责人:Ankit Ashok Parekh
-
依托单位:
Sustained Attention Neuroimaging in Sleep Apnea
-
批准号:10343780
-
项目类别:
-
资助金额:$16.23万
-
财政年份:2021
-
负责人:Ankit Ashok Parekh
-
依托单位:
Sustained Attention Neuroimaging in Sleep Apnea
-
批准号:10557102
-
项目类别:
-
资助金额:$16.24万
-
财政年份:2021
-
负责人:Ankit Ashok Parekh
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: